The Anela protocol Epitalon is a structured Epithalon cycle used for sleep and longevity research. Here's how the dosing, cycle length, and safety compare.
The Anela protocol Epitalon is a packaged Epitalon (Epithalon) cycle — most versions call for roughly 5–10 mg per day for 10–20 days, followed by a break of several months. The "Anela" label describes how a clinic or vendor structures that cycle, not a different drug. Epitalon is not FDA-approved for human use in the United States.
What the Anela Protocol Epitalon Actually Is
You will find the term "Anela protocol" in clinic menus, vendor blogs, and peptide forums rather than in the medical literature. It describes a service model: an intake consult, baseline labs, a suggested injection schedule, and sometimes add-on compounds. The active ingredient is still Epitalon, a synthetic tetrapeptide also spelled Epithalon.
Epitalon was developed by Russian researcher Vladimir Khavinson and studied there in small, older trials. Most of what circulates online traces back to that body of work plus anecdotal user reports. Large randomized human trials of Epitalon do not exist.
The Anela protocol is a scheduling and packaging term; the active compound is Epitalon, also spelled Epithalon.
Typical Epitalon Dosing and Cycle Length
Because there is no FDA-approved label, no official dose exists. The figures below reflect patterns that are most commonly reported online, not a clinical standard.
- Daily amount: frequently reported at 5–10 mg per day, with some users reporting 1–5 mg.
- Cycle length: usually 10–20 consecutive days.
- Frequency: often one or two cycles per year rather than continuous use.
- Route: subcutaneous injection is most common; nasal sprays, capsules, and sublingual drops are also sold.
- Timing: often dosed in the evening, based on the theory that it supports circadian signaling.
| Route | Reported daily amount | Reported cycle length | Notes |
|---|---|---|---|
| Subcutaneous injection | 5–10 mg | 10–20 days | Most widely discussed; requires sterile technique |
| Intranasal spray | 1–5 mg | 10–20 days | Absorption is poorly documented |
| Oral or sublingual | Varies widely | 2–8 weeks | Peptides are generally broken down in the digestive tract |
How the Anela Protocol Compares With Other Peptide Protocols
Most people research Epitalon alongside other compounds rather than on its own. The comparison below is about structure and purpose, not about which option is stronger.
Someone focused on recovery or body composition is more likely to read about a cjc-1295 ipamorelin protocol, while metabolic and mitochondrial questions tend to lead toward a mots-c peptide dosage protocol. Fat-metabolism research is usually framed around an aod 9604 dosage protocol, and sleep quality is the entry point for Epitalon.
| Protocol | Primary research focus | Commonly reported cycle | Typical route |
|---|---|---|---|
| Anela protocol Epitalon | Sleep, circadian rhythm, telomerase research | 10–20 days, 1–2 times per year | Subcutaneous injection |
| cjc-1295 ipamorelin protocol | Growth hormone pulse support | 8–12 weeks | Subcutaneous injection |
| mots-c peptide dosage protocol | Metabolic and mitochondrial markers | 4–8 weeks | Subcutaneous injection |
| aod 9604 dosage protocol | Fat metabolism research | 8–12 weeks | Subcutaneous injection |
Why People Use Epitalon for Sleep and Longevity
Two claims drive most of the interest: better sleep and longer telomeres. Both rest on thin human evidence.
Sleep and circadian rhythm
Older Russian studies reported improvements in sleep quality and melatonin rhythm in older adults. Anecdotal reports of epitalon for sleep are common, but they are self-reported, uncontrolled, and easy to attribute to other lifestyle changes happening at the same time.
Telomerase and aging research
Khavinson's group reported telomerase activation in cell and animal models. No human trial has shown that Epitalon extends lifespan, and telomerase activation remains a theoretical cancer concern that researchers take seriously.
What is actually sold
Most products are labeled as an epitalon peptide supplement, a research chemical, or "not for human consumption." That labeling matters legally and for product purity.
Safety, Side Effects, and Legal Status
- FDA status: Epitalon is not approved for human use in the United States.
- Product quality: research-chemical supply chains vary widely, and independent third-party testing is uncommon.
- Commonly reported effects: injection-site redness, irritation, and mild fatigue.
- Unknowns: long-term safety, immune effects, and interactions with prescription drugs are largely unstudied.
- Cancer question: because telomerase activation could theoretically promote tumor growth, people with a cancer history should be especially cautious.
Talk with a licensed healthcare professional before starting any peptide, particularly if you take prescription medication or have a hormone-sensitive condition. Self-directed dosing without monitoring is the most common way people run into trouble.
Questions to Ask Before Starting an Anela-Style Cycle
- Who compounds the Epitalon, and can they provide a certificate of analysis?
- What monitoring is included, and who reviews the results?
- How long is the break between cycles, and what is that length based on?
- What other peptides are being stacked, and are interactions considered?
- What is the plan if side effects appear mid-cycle?
Also ask whether the provider treats "Anela protocol" as a specific documented protocol or simply as branding. A name alone is not evidence of safety or effectiveness.
The Bottom Line
- Epitalon is not FDA-approved for human use in the United States.
- The Anela protocol Epitalon is a scheduling and packaging term, not a distinct medication.
- Most reported Epitalon cycles run 10–20 days at 5–10 mg per day, once or twice a year.
- No human trial has shown that Epitalon extends lifespan or reverses aging.
Frequently Asked Questions
What is the Anela protocol Epitalon?
The Anela protocol Epitalon is a branded way of describing a structured Epitalon (Epithalon) cycle, usually 5–10 mg per day for 10–20 days with a long break afterward. The active compound is a synthetic tetrapeptide studied in Russia, not a unique drug created by the protocol. You will not find the term in peer-reviewed medical literature.
How much Epitalon do people take per day?
Reported doses usually fall between 5 mg and 10 mg per day by subcutaneous injection, though some users report 1–5 mg. There is no FDA-approved dose because Epitalon is not approved for human use. Cycle length, typically 10–20 days, may matter more than the exact daily amount.
Is Epitalon FDA-approved, and can you buy it legally?
Epitalon is not FDA-approved for human use in the United States. It is commonly sold as a research chemical labeled "not for human consumption," which places the buyer outside normal pharmaceutical safeguards. Purity and sterility of those products are not guaranteed by the FDA.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.